Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer.

Saigi M, Alburquerque-Bejar JJ, Mc Leer-Florin A, Pereira C, Pros E, Romero OA, Baixeras N, Esteve-Codina A, Nadal E, Brambilla E, Sanchez-Cespedes M.

Clin Cancer Res. 2018 Sep 15;24(18):4579-4587. doi: 10.1158/1078-0432.CCR-18-0267. Epub 2018 Jun 13.

PMID:
29898990
2.

Predictive and Prognostic Brain Metastases Assessment in Luminal Breast Cancer Patients: FN14 and GRP94 from Diagnosis to Prophylaxis.

Martínez-Aranda A, Hernández V, Moreno F, Baixeras N, Cuadras D, Urruticoechea A, Gil-Gil M, Vidal N, Andreu X, Seguí MA, Ballester R, Castella E, Sierra A.

Front Oncol. 2017 Dec 1;7:283. doi: 10.3389/fonc.2017.00283. eCollection 2017.

3.

Visceral leishmaniasis with mediastinal lymphadenopathy diagnosed with endoscopic ultrasound-guided fine needle aspiration.

Sihuay D, Gornals JB, Saumoy M, Baixeras N, Sánchez A, Consiglieri CF, Catalá I.

Rev Esp Enferm Dig. 2016 Nov;108(11):736-738.

4.

Combined Bronchial Artery Embolization and Endobronchial Resection for Bronchial Carcinoid: A Safety and Feasibility Pilot Study.

Salamonsen M, Tazi-Mezalek R, López-Lisbona R, Cubero N, Baixeras N, Dominguez J, Dorca J, Rosell A.

Respiration. 2016;91(1):63-8. doi: 10.1159/000442487. Epub 2015 Dec 3.

5.

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.

Martínez-Aranda A, Hernández V, Guney E, Muixí L, Foj R, Baixeras N, Cuadras D, Moreno V, Urruticoechea A, Gil M, Oliva B, Moreno F, González-Suarez E, Vidal N, Andreu X, Seguí MA, Ballester R, Castella E, Sierra A.

Oncotarget. 2015 Dec 29;6(42):44254-73. doi: 10.18632/oncotarget.5471.

6.

Ecto-nucleotidases activities in the contents of ovarian endometriomas: potential biomarkers of endometriosis.

Texidó L, Romero C, Vidal A, García-Valero J, Fernández Montoli ME, Baixeras N, Condom E, Ponce J, García-Tejedor A, Martín-Satué M.

Mediators Inflamm. 2014;2014:120673. doi: 10.1155/2014/120673. Epub 2014 Sep 3.

7.

Protecting the underscreened women in developed countries: the value of HPV test.

Ibáñez R, Autonell J, Sardà M, Crespo N, Pique P, Pascual A, Martí C, Fibla M, Gutiérrez C, Lloveras B, Moreno-Crespi J, Torrent A, Baixeras N, Alejo M, Bosch FX, de Sanjosé S.

BMC Cancer. 2014 Aug 8;14:574. doi: 10.1186/1471-2407-14-574.

8.

Diagnosis of Whipple's disease by EUS-guided-FNA and endoscopic biopsy at the same procedure.

Gornals JB, Baixeras N, Paúles MJ, Mast R, Pujol R.

Gastrointest Endosc. 2012 Apr;75(4):895-6; discussion 895-6. doi: 10.1016/j.gie.2011.11.030. Epub 2012 Jan 28. No abstract available.

PMID:
22284090
9.

Performance of the digene LQ, RH and PS HPVs genotyping systems on clinical samples and comparison with HC2 and PCR-based Linear Array.

Godínez JM, Tous S, Baixeras N, Moreno-Crespi J, Alejo M, Lejeune M, Bravo IG, Bosch FX, de Sanjosé S.

Infect Agent Cancer. 2011 Nov 18;6:23. doi: 10.1186/1750-9378-6-23.

10.

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness.

Molleví DG, Aytes A, Padullés L, Martínez-Iniesta M, Baixeras N, Salazar R, Ramos E, Figueras J, Capella G, Villanueva A.

Br J Cancer. 2008 Nov 18;99(10):1718-25. doi: 10.1038/sj.bjc.6604747. Epub 2008 Oct 28.

11.

Primitive round cell liposarcoma of the omentum: diagnostic value of ultrastructural study.

Alameda F, Corominas JM, Barranco C, Munné A, Baro T, Baixeras N, Lloreta J, Serrano S.

Ultrastruct Pathol. 2003 Nov-Dec;27(6):433-7.

PMID:
14660282
12.

Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy.

Lloreta J, Domingo P, Pujol RM, Arroyo JA, Baixeras N, Matias-Guiu X, Gilaberte M, Sambeat MA, Serrano S.

Virchows Arch. 2002 Dec;441(6):599-604. Epub 2002 Oct 24.

PMID:
12461618

Supplemental Content

Loading ...
Support Center